Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00580 | 2,5-Dioxopyrrolidin-1-Yl 4-Methyl-4-((2-Methyl-5-Oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-Yl)disulfanyl)pentanoate | 1286715-33-0 |
| 2, 5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00581 | 3-((2,5-Dioxopyrrolidin-1-Yl)oxy)-3-Oxopropyl Acrylate | 1311459-55-8 |
| 3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropyl acrylate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00582 | Fmoc-PEG4-NHS ester | 1314378-14-7 |
| Fmoc-PEG4-NHS ester is a PEG derivative containing an Fmoc-protected amine and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The Fmoc group can be deprotected under basic conditions to obtain the free amine which can be used for further conjugations. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. | Inquiry | |
| BADC-00583 | mPEG9-NHS ester | 1316189-13-5 |
| m-PEG9-NHS ester is a PEG derivative containing an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The hydrophilic PEG spacer increases solubility in aqueous media. m-PEG9-NHS ester is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00584 | Mal-amido-PEG8-acid | 1334177-86-4 |
| Mal-amido-PEG8-acid is a PEG derivative containing a maleimide group and a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol. | Inquiry | |
| BADC-00586 | Boc-NMe-Val-Val-Dil-Dap-OH | 1352202-13-1 |
| Boc-NMe-Val-Val-Dil-Dap-OH is a Lyn-derived linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00589 | N-Methyl-N-[(3-methyldithio)-1-oxopropyl]-L-alanine | 138148-62-6 |
| N-Methyl-N-[(3-methyldithio)-1-oxopropyl]-L-alanine, a microtubule inhibitor, is a PEG linker used in antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00590 | DBCO-C6-NHS ester | 1384870-47-6 |
| Inquiry | ||
| BADC-00591 | DBCO-NHS ester 3 | 1393350-27-0 |
| Inquiry | ||
| BADC-00595 | 6-(Boc-amino)hexyl bromide | 142356-33-0 |
| Boc-NH-C6-Br is a cleavable linker used for antibody-drug conjugates (ADC). | Inquiry | |
| BADC-00597 | Sulfo-SIAB sodium | 144650-93-1 |
| Sulfo-SIAB sodium is a nonclaevable monovalent bilinker. | Inquiry | |
| BADC-00599 | 2,5-Dioxopyrrolidin-1-yl 3-((3-((3-(trityloxy)propanoyl)oxy)propanoyl)oxy)propanoate | 145069-77-8 |
| 2, 5-Dioxopyrrolidin-1-yl 3-((3-((3-(trityloxy)propanoyl)oxy)propanoyl)oxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00602 | Mal-L-PA-NH-Boc | 1491152-23-8 |
| Mal-L-PA-NH-Boc is a noncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-00603 | Mal-PEG3-NHS ester | 1537892-36-6 |
| Mal-PEG3-NHS ester is a non-cleavable ADC linker containing the Maleimide group. It can be used to prepare antibody conjugated drugs (ADCs). | Inquiry | |
| BADC-00616 | 2,5-Dioxopyrrolidin-1-yl 3-Hydroxypropanoate | 178106-34-8 |
| 2, 5-Dioxopyrrolidin-1-yl 3-hydroxypropanoate is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00618 | Mal-PEG4-VA | 1800456-31-8 |
| Mal-PEG4-VA is a noncleavable ADC linker containing a Maleimide group. Mal-PEG4-VA is used for making antibody-drug conjugate. | Inquiry | |
| BADC-00621 | CL2A | 1846605-04-6 |
| CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker. | Inquiry | |
| BADC-00626 | 4-Formyl-N-(2-Methoxyethyl)benzamide | 199679-16-8 |
| 4-Formyl-N-(2-methoxyethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00628 | MAL-Tri-EG-Osu | 2055353-77-8 |
| MAL-tri-EG-Osu is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00636 | PDB-Pfp | 2088570-81-2 |
| Inquiry |
